Chenomx and Umetrics Partner to Provide Metabolomics Analysis Platform
News Apr 25, 2006
This partnership combines Chenomx’s metabolic profiling software with Umetrics’ multivariate analysis software, providing researchers with a turn-key solution for discovering biologically relevant patterns in NMR spectra.
"Metabolomics researchers are faced with two key challenges," explains Jack Newton, Director of Product Development for Chenomx.
"First, they must analyze large NMR data sets, potentially consisting of thousands of NMR spectra, to find meaningful patterns in their data."
"Translating these patterns into biologically relevant information in the form of metabolite identification and quantification is the second key challenge."
"These two processes are tightly coupled, and the decision to partner with Umetrics to make the process as intuitive and as effortless as possible for the end-user was a natural one."
Jan Wahlstrom, European CEO and Sales Manager, adds, "This partnership is great news for scientists working in metabonomics and metabolomics as it provides them with a seamless interface between data collection and data analysis, allowing them to get on with the science."
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE
Nonalcoholic fatty liver disease produces no noticeable symptoms, but one out of every five people with it will go on to develop a more serious conditions such as nonalcoholic steatohepatosis and cirrhosis. Three new studies investigate how mitochondrial energy production is altered by the progress of fatty liver disease.READ MORE